252 related articles for article (PubMed ID: 30564416)
21. GES polypharmacology fingerprints: a novel approach for drug repositioning.
Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
[TBL] [Abstract][Full Text] [Related]
22. Enhancing the Enrichment of Pharmacophore-Based Target Prediction for the Polypharmacological Profiles of Drugs.
Wang X; Pan C; Gong J; Liu X; Li H
J Chem Inf Model; 2016 Jun; 56(6):1175-83. PubMed ID: 27187084
[TBL] [Abstract][Full Text] [Related]
23. Target RNA modification for epigenetic drug repositioning in neuroblastoma: computational omics proximity between repurposing drug and disease.
Ma P; Yue L; Zhang S; Hao D; Wu Z; Xu L; Du G; Xiao P
Aging (Albany NY); 2020 Oct; 12(19):19022-19044. PubMed ID: 33044945
[TBL] [Abstract][Full Text] [Related]
24. A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures.
Mokou M; Narayanasamy S; Stroggilos R; Balaur IA; Vlahou A; Mischak H; Frantzi M
Methods Mol Biol; 2023; 2684():59-99. PubMed ID: 37410228
[TBL] [Abstract][Full Text] [Related]
25. Exploring the molecular mechanisms of Traditional Chinese Medicine components using gene expression signatures and connectivity map.
Yoo M; Shin J; Kim H; Kim J; Kang J; Tan AC
Comput Methods Programs Biomed; 2019 Jun; 174():33-40. PubMed ID: 29650251
[TBL] [Abstract][Full Text] [Related]
26. Polypharmacology: challenges and opportunities in drug discovery.
Anighoro A; Bajorath J; Rastelli G
J Med Chem; 2014 Oct; 57(19):7874-87. PubMed ID: 24946140
[TBL] [Abstract][Full Text] [Related]
27. Querying genomic databases: refining the connectivity map.
Segal MR; Xiong H; Bengtsson H; Bourgon R; Gentleman R
Stat Appl Genet Mol Biol; 2012 Jan; 11(2):. PubMed ID: 22499690
[TBL] [Abstract][Full Text] [Related]
28. Drug repurposing in psoriasis, performed by reversal of disease-associated gene expression profiles.
Ahmed F; Ho SG; Samantasinghar A; Memon FH; Rahim CSA; Soomro AM; Pratibha ; Sunildutt N; Kim KH; Choi KH
Comput Struct Biotechnol J; 2022; 20():6097-6107. PubMed ID: 36420161
[TBL] [Abstract][Full Text] [Related]
29. Polypharmacology in Precision Oncology: Current Applications and Future Prospects.
Antolin AA; Workman P; Mestres J; Al-Lazikani B
Curr Pharm Des; 2016; 22(46):6935-6945. PubMed ID: 27669965
[TBL] [Abstract][Full Text] [Related]
30. The polypharmacology of natural products.
Ho TT; Tran QT; Chai CL
Future Med Chem; 2018 Jun; 10(11):1361-1368. PubMed ID: 29673257
[TBL] [Abstract][Full Text] [Related]
31. A data-driven methodology towards evaluating the potential of drug repurposing hypotheses.
Prieto Santamaría L; Ugarte Carro E; Díaz Uzquiano M; Menasalvas Ruiz E; Pérez Gallardo Y; Rodríguez-González A
Comput Struct Biotechnol J; 2021; 19():4559-4573. PubMed ID: 34471499
[TBL] [Abstract][Full Text] [Related]
32. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
33. Drug repurposing: Known knowns to unknown unknowns - Network analysis of the repurposome.
Cavalla D; Crichton G
Drug Discov Today; 2023 Jul; 28(7):103639. PubMed ID: 37236525
[TBL] [Abstract][Full Text] [Related]
34. Graphical Learning and Causal Inference for Drug Repurposing.
Xu T; Zhao J; Xiong M
medRxiv; 2023 Aug; ():. PubMed ID: 37577650
[TBL] [Abstract][Full Text] [Related]
35. A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.
Lee SY; Song MY; Kim D; Park C; Park DK; Kim DG; Yoo JS; Kim YH
Front Pharmacol; 2019; 10():1653. PubMed ID: 32063857
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
37. Computational Drug Repurposing: Current Trends.
Karaman B; Sippl W
Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
[TBL] [Abstract][Full Text] [Related]
38. Repurposing of ginseng extract as topoisomerase I inhibitor based on the comparative analysis of gene expression patterns.
Byun MR; Kim CH; Lee HS; Choi JW; Lee SK
Phytochemistry; 2019 Aug; 164():223-227. PubMed ID: 31181353
[TBL] [Abstract][Full Text] [Related]
39. Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development.
Stefan SM; Rafehi M
Drug Dev Res; 2024 Feb; 85(1):e22125. PubMed ID: 37920929
[TBL] [Abstract][Full Text] [Related]
40. A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures.
Mokou M; Lygirou V; Angelioudaki I; Paschalidis N; Stroggilos R; Frantzi M; Latosinska A; Bamias A; Hoffmann MJ; Mischak H; Vlahou A
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
